Aminophyllin and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aminophyllin (aminophylline) and Thalidomide (thalidomide). Common drug interactions include drug effect increased among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Aminophyllin and Thalidomide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Aminophyllin?

Aminophyllin has active ingredients of aminophylline. eHealthMe is studying from 3,118 Aminophyllin users. Check the latest studies of Aminophyllin.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.



On Jul, 09, 2026

12 people who take Aminophyllin and Thalidomide together, and have interactions are studied.

Aminophyllin and Thalidomide drug interactions.

What are the common drug interactions of Aminophyllin and Thalidomide, by gender? *:

female:

  1. Drug effect increased
  2. Dyspnoea (difficult or laboured respiration)
  3. Electrocardiogram st segment elevation
  4. Electrocardiogram t wave inversion
  5. Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs)
  6. Hypoxia (low oxygen in tissues)
  7. Pain in jaw
  8. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
  9. Respiratory distress (difficulty in breathing)
  10. Wheezing (a high-pitched whistling sound made while you breath)

male:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cardiac failure
  4. Congestive cardiomyopathy (weakening of heart muscle)
  5. Hypersensitivity

What are the common drug interactions of Aminophyllin and Thalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Electrocardiogram st segment elevation
  3. Electrocardiogram t wave inversion
  4. Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs)
  5. Hypersensitivity
  6. Hypoxia (low oxygen in tissues)
  7. Pain in jaw
  8. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
  9. Respiratory distress (difficulty in breathing)
  10. Wheezing (a high-pitched whistling sound made while you breath)

60+:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cardiac failure
  4. Congestive cardiomyopathy (weakening of heart muscle)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 91.67%
  2. Asthma: 6 people, 50.00%
  3. Type 2 Diabetes: 1 person, 8.33%
  4. Enlarged Heart: 1 person, 8.33%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
  6. Bone Disorder: 1 person, 8.33%
  7. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 8.33%
  8. Cardiac Failure: 1 person, 8.33%
  9. Congestive Cardiomyopathy (weakening of heart muscle): 1 person, 8.33%
  10. Cough: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aminophyllin and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aminophyllin and Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aminophyllin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aminophyllin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aminophylline and thalidomide (the active ingredients of Aminophyllin and Thalidomide, respectively), and Aminophyllin and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: